Levetiracetam Tablet, Film Coated
Product Images NDC 68084-859

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 68084-859). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000 mg Blister

Label sheet containing multiple individual labels for Levetiracetam 1000 mg tablet, film coated, manufactured by American Health Packaging. Each label includes the product name, strength, dosage form, a barcode, lot number, expiration date placeholders, and American Health Packaging's location in Columbus, Ohio.*

FDA Label Image

1000 mg Carton

Levetiracetam Tablets USP 1000 mg film-coated tablets, oral administration. The label indicates a package size of 100 tablets (10 x 10) and includes storage instructions, dosing note, and pharmacist dispensing guidance. The product is labeled Rx Only and manufactured and distributed by American Health Packaging, Columbus, Ohio.*

FDA Label Image

250 mg Blister

Multiple identical labels for Levetiracetam Tablet USP 250 mg, film-coated oral tablets. Each label includes the drug name, strength, a barcode, placeholder expiration and lot number fields, and states American Health Packaging as the labeler from Columbus, Ohio.*

FDA Label Image

250 mg Carton

Levetiracetam 250 mg film-coated tablets label from American Health Packaging. The label indicates a package size of 100 tablets (10 x 10). It includes directions for pharmacists and storage instructions, as well as barcode and NDC information.*

FDA Label Image

500 mg Blister

Levetiracetam Tablet USP 500 mg film-coated tablet label from American Health Packaging. The label includes the product name, strength, dosage form, bar code, and space for the lot number and expiration date. The label also features the labeler's location in Columbus, Ohio.*

FDA Label Image

500 mg Carton

Levetiracetam 500 mg film-coated tablets label, indicating a package size of 100 tablets (10 x 10) for oral use. The label includes the NDC code 68084-870-01 and notes that the product is Rx only. It is packaged and distributed by American Health Packaging. The label also contains storage instructions, dosage form, and a pharmacist dispensing note.*

FDA Label Image

750 mg Blister

This image shows multiple repeating labels for Levetiracetam Tablet USP 750 mg, film-coated tablets for oral use. Each label includes the drug name, strength (750 mg), a barcode, placeholder text for expiration date and lot number, and the labeler name American Health Packaging, Columbus, Ohio 43217.*

FDA Label Image

750 mg Carton

Levetiracetam 750 mg film-coated tablets label from American Health Packaging. The label indicates 100 tablets per package and displays the NDC 68084-882-01. It includes dispensing instructions, storage conditions, and manufacturer information for American Health Packaging in Columbus, Ohio.*

FDA Label Image

Ahp85901

Levetiracetam 750 mg film-coated oral tablet, imprint E 10 on one side, smooth and oval in shape, pale blue in color. Manufacturer: American Health Packaging.*

FDA Label Image

Ahp87001

Levetiracetam 250 mg film-coated oral tablet, oblong beige, scored with imprint 'E 11' on one side. Distributed by American Health Packaging.*

FDA Label Image

Ahp88201

Levetiracetam 250 mg film-coated oral tablet imprinted with "E 12" on one side and plain on the other, provided by American Health Packaging.*

FDA Label Image

Ahp89301

Levetiracetam 250 mg film-coated oral tablet, white and oblong with the imprint 'E 13' on one side and smooth on the other. Manufactured by American Health Packaging.*

FDA Label Image

Figure 1

A bar graph showing the percentage of patients for three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). The y-axis represents the percentage of patients, with values ranging from 0% to 45%.*

FDA Label Image

Figure 2

A bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The vertical axis shows percentage of patients from 0% to 45%. Percentage values above each bar are 6.3% for placebo, 20.8% for 1000 mg/day, and 35.2% for 2000 mg/day doses of Levetiracetam.*

FDA Label Image

Figure 3

A bar chart comparing the percentage of patients in two groups: those taking a placebo (N=104) and those taking Levetiracetam 3000 mg/day (N=180). The chart shows approximately 14.4% of patients in the placebo group and 39.4% of patients in the Levetiracetam group achieving the measured outcome.*

FDA Label Image

Figure 4

A bar chart comparing the percentage of patients between two groups: Placebo (N=97) with 19.6% and Levetiracetam (N=101) with 44.6%. The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Figure 5

A bar chart comparing the percentage of patients between two groups: Placebo (N=51) and Levetiracetam (N=58). The y-axis shows the percentage of patients from 0% to 45%. The Placebo group shows approximately 19.6%, while the Levetiracetam group shows approximately 43.1%.*

FDA Label Image

Figure 6

A bar graph comparing the percentage of patients between two groups: Placebo (N=84) and Levetiracetam (N=79). The y-axis represents the percentage of patients ranging from 0% to 100%, with the Placebo group showing 45.2% and the Levetiracetam group showing 72.2%.*

FDA Label Image

Structure

Chemical structure diagram of Levetiracetam, illustrating its molecular arrangement including a pyrrolidone ring and various attached groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.